The Senate health committee has scheduled a key vote next week on Dr. Heidi Overton, President Trump's nominee to serve as commissioner of the Food and Drug Administration, according to The Hill's report on the committee's scheduling. The Hill, citing a committee press release, said the vote on Overton's nomination is set for Nov. 18.

The Hill reported that Overton's path forward is not assured, even as the vote is scheduled. The summary of that report does not say what obstacles, if any, lie ahead for the nomination or which committee members have stated positions on it.

The same report states that the committee will also vote on additional matters. The summary available for this story cuts off before identifying them, so those items are not described here.

The report was written by Nathaniel Weixel of The Hill. Because the source material is limited to a short summary, this account is confined to the scheduling of the vote and the uncertainty the report describes. Further details would require the full text of the original report or the committee's own release.

Sources: The Hill: Senate committee sets key vote for Trump FDA nominee.